vs

Side-by-side financial comparison of Genius Sports Ltd (GENI) and WATTS WATER TECHNOLOGIES INC (WTS). Click either name above to swap in a different company.

WATTS WATER TECHNOLOGIES INC is the larger business by last-quarter revenue ($677.3M vs $510.9M, roughly 1.3× Genius Sports Ltd). WATTS WATER TECHNOLOGIES INC runs the higher net margin — 14.7% vs -12.3%, a 27.0% gap on every dollar of revenue. Genius Sports Ltd produced more free cash flow last quarter ($69.6M vs $6.6M). Over the past eight quarters, Genius Sports Ltd's revenue compounded faster (129.2% CAGR vs 6.5%).

Genius Sports is a sports data and technology company that provides data management, video streaming and integrity services to sports leagues, bookmakers and media companies.

AERCO International, Inc. is a manufacturer and supplier of commercial condensing boilers, high efficiency water heating equipment and energy recovery systems in the HVAC/plumbing industry across a variety of markets including education, lodging, government, office buildings, healthcare, industrial and multifamily housing. In 1949, AERCO introduced the industry's first semi-instantaneous, tankless steam-to-water water heater. In 1988, AERCO introduced the first condensing and fully modulating...

GENI vs WTS — Head-to-Head

Bigger by revenue
WTS
WTS
1.3× larger
WTS
$677.3M
$510.9M
GENI
Higher net margin
WTS
WTS
27.0% more per $
WTS
14.7%
-12.3%
GENI
More free cash flow
GENI
GENI
$63.0M more FCF
GENI
$69.6M
$6.6M
WTS
Faster 2-yr revenue CAGR
GENI
GENI
Annualised
GENI
129.2%
6.5%
WTS

Income Statement — Q4 FY2025 vs Q1 FY2026

Metric
GENI
GENI
WTS
WTS
Revenue
$510.9M
$677.3M
Net Profit
$-63.0M
$99.6M
Gross Margin
25.2%
48.1%
Operating Margin
-11.5%
19.6%
Net Margin
-12.3%
14.7%
Revenue YoY
21.4%
Net Profit YoY
34.6%
EPS (diluted)
$2.97

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
GENI
GENI
WTS
WTS
Q1 26
$677.3M
Q4 25
$510.9M
$625.1M
Q3 25
$335.4M
$611.7M
Q2 25
$215.2M
$643.7M
Q1 25
$119.7M
$558.0M
Q4 24
$413.0M
$540.4M
Q3 24
$285.8M
$543.6M
Q2 24
$184.1M
$597.3M
Net Profit
GENI
GENI
WTS
WTS
Q1 26
$99.6M
Q4 25
$-63.0M
$83.7M
Q3 25
$82.2M
Q2 25
$-47.3M
$100.9M
Q1 25
$-25.5M
$74.0M
Q4 24
$-85.5M
$67.5M
Q3 24
$-47.1M
$69.1M
Q2 24
$-35.5M
$82.0M
Gross Margin
GENI
GENI
WTS
WTS
Q1 26
48.1%
Q4 25
25.2%
49.5%
Q3 25
24.2%
48.8%
Q2 25
19.1%
50.6%
Q1 25
10.7%
48.8%
Q4 24
16.7%
46.7%
Q3 24
20.5%
47.3%
Q2 24
18.6%
47.7%
Operating Margin
GENI
GENI
WTS
WTS
Q1 26
19.6%
Q4 25
-11.5%
18.2%
Q3 25
-15.3%
18.2%
Q2 25
-21.0%
21.0%
Q1 25
-20.3%
15.7%
Q4 24
-18.0%
16.5%
Q3 24
-13.9%
17.1%
Q2 24
-16.8%
18.7%
Net Margin
GENI
GENI
WTS
WTS
Q1 26
14.7%
Q4 25
-12.3%
13.4%
Q3 25
13.4%
Q2 25
-22.0%
15.7%
Q1 25
-21.3%
13.3%
Q4 24
-20.7%
12.5%
Q3 24
-16.5%
12.7%
Q2 24
-19.3%
13.7%
EPS (diluted)
GENI
GENI
WTS
WTS
Q1 26
$2.97
Q4 25
$2.50
Q3 25
$2.45
Q2 25
$3.01
Q1 25
$2.21
Q4 24
$2.02
Q3 24
$2.06
Q2 24
$2.44

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
GENI
GENI
WTS
WTS
Cash + ST InvestmentsLiquidity on hand
$280.6M
$374.7M
Total DebtLower is stronger
$197.8M
Stockholders' EquityBook value
$724.5M
$2.1B
Total Assets
$1.1B
$2.9B
Debt / EquityLower = less leverage
0.09×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
GENI
GENI
WTS
WTS
Q1 26
$374.7M
Q4 25
$280.6M
$405.5M
Q3 25
$110.2M
$457.7M
Q2 25
$110.2M
$369.3M
Q1 25
$110.2M
$336.8M
Q4 24
$100.3M
$386.9M
Q3 24
$100.3M
$303.9M
Q2 24
$100.3M
$279.4M
Total Debt
GENI
GENI
WTS
WTS
Q1 26
$197.8M
Q4 25
Q3 25
Q2 25
Q1 25
Q4 24
Q3 24
Q2 24
Stockholders' Equity
GENI
GENI
WTS
WTS
Q1 26
$2.1B
Q4 25
$724.5M
$2.0B
Q3 25
$572.4M
$2.0B
Q2 25
$572.4M
$1.9B
Q1 25
$572.4M
$1.8B
Q4 24
$573.0M
$1.7B
Q3 24
$573.0M
$1.7B
Q2 24
$573.0M
$1.6B
Total Assets
GENI
GENI
WTS
WTS
Q1 26
$2.9B
Q4 25
$1.1B
$2.9B
Q3 25
$792.3M
$2.7B
Q2 25
$792.3M
$2.6B
Q1 25
$792.3M
$2.5B
Q4 24
$775.7M
$2.4B
Q3 24
$775.7M
$2.4B
Q2 24
$775.7M
$2.4B
Debt / Equity
GENI
GENI
WTS
WTS
Q1 26
0.09×
Q4 25
Q3 25
Q2 25
Q1 25
Q4 24
Q3 24
Q2 24

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
GENI
GENI
WTS
WTS
Operating Cash FlowLast quarter
$81.9M
$17.9M
Free Cash FlowOCF − Capex
$69.6M
$6.6M
FCF MarginFCF / Revenue
13.6%
1.0%
Capex IntensityCapex / Revenue
2.4%
Cash ConversionOCF / Net Profit
0.18×
TTM Free Cash FlowTrailing 4 quarters
$33.5M
$317.3M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
GENI
GENI
WTS
WTS
Q1 26
$17.9M
Q4 25
$81.9M
$154.7M
Q3 25
$-4.8M
$122.4M
Q2 25
$-1.2M
$69.7M
Q1 25
$-14.6M
$55.2M
Q4 24
$14.9M
$139.5M
Q3 24
$-9.2M
$90.7M
Q2 24
$85.3M
Free Cash Flow
GENI
GENI
WTS
WTS
Q1 26
$6.6M
Q4 25
$69.6M
$140.3M
Q3 25
$-14.2M
$110.9M
Q2 25
$-5.8M
$59.5M
Q1 25
$-16.0M
$45.6M
Q4 24
$11.3M
$127.5M
Q3 24
$-11.6M
$84.3M
Q2 24
$78.5M
FCF Margin
GENI
GENI
WTS
WTS
Q1 26
1.0%
Q4 25
13.6%
22.4%
Q3 25
-4.2%
18.1%
Q2 25
-2.7%
9.2%
Q1 25
-13.4%
8.2%
Q4 24
2.7%
23.6%
Q3 24
-4.1%
15.5%
Q2 24
13.1%
Capex Intensity
GENI
GENI
WTS
WTS
Q1 26
Q4 25
2.4%
2.3%
Q3 25
2.8%
1.9%
Q2 25
2.1%
1.6%
Q1 25
1.2%
1.7%
Q4 24
0.9%
2.2%
Q3 24
0.9%
1.2%
Q2 24
1.1%
Cash Conversion
GENI
GENI
WTS
WTS
Q1 26
0.18×
Q4 25
1.85×
Q3 25
1.49×
Q2 25
0.69×
Q1 25
0.75×
Q4 24
2.07×
Q3 24
1.31×
Q2 24
1.04×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

GENI
GENI

Segment breakdown not available.

WTS
WTS

segment net$517.8M76%
Other$159.5M24%

Related Comparisons